Antipsychotics Flashcards
Fluphenazine (Prolixin) Dosing
Tablet: 1,2.5,5,10mg Oral Elixir: 2.5mg/5ml Concentrate: 5mg/ml Injection (IR): 2.5mg/ml LA Depot: 25mg/ml Initiate 2.5-10mg/day Q6-8 hrs; dose range: 1-50mg/day; MAX: 100mg/day
Fluphenazine (Prolix) Clinical
2D6 substrate
Haloperidol (Haldol) Dosing
Tablet: 0.5,1,2,5,10,20mg Oral Soln: 2mg/ml Injection (IR): 5mg/ml LA Depot: 50mg/ml, 100mg/ml Initiate 1-15mg/day, divide doses if needed, MAX: 100mg/day
Haloperidol (Haldol) Clinical
2D6, 3A4 substrate
Loxapine (Loxitane, Adasuve) Dosing
Oral inhalation powder: 10mg/dose
10mg dose Q24 hrs
Loxapine (Loxitane, Adasuve) Clinical
“Atypical typical”
Adasuve oral inhalation power has REMS - must be in hospital setting w/ emergency service access, CI’d w/ hx of lung disease, monitor closely for bronchospasm
Perphenazine (Trilafon) Clinical
Increased use in recent years due to CATIE study
Pimozide (Orap) Clinical
3A4 substrate, QTc prolongation limits use, usual clinical use limited to Tourette’s disorder
Thioridazine (Mellaril) Clinical
Significant QTc prolongation limits use, not generally initiated as new therapy, informed consent necessary
Thiothixene (Navane) Clinical
1A2 substrate
Aripiprazole (Abilify and Abilify Maintena) Dosing
Tablet: 2,5,10,15,20,30mg
LA Depot: 300mg/vial, 400mg/vial
Liquid: 1mg/ml
Initiate 10-15mg QD, titrate Q2 weeks, MAX: 30mg/day
IR Injection: 9.75mg IM, 2 hrs between doses, MAX: 3 injections/day
LA Depot: 400mg IM once monthly, overlap w/ oral x2 weeks
Aripiprazole (Abilify and Abilify Maintena) Clinical
2D6, 3A4 substrate
Very long T1/2
FDA approved for MDD in combo with antidepressant (not LAI)
Aripiprazole lauroxil (Aristada) Dosing
LA Depot: 442mg/vial, 662mg/vial, 882mg/vial
Initiate based on oral dose:
10mg QD: 442mg
15mg QD: 662mg
20mg QD: 882 mg
Any dose can be given Q4 weeks, 882mg Q6 weeks if tolerated, MUST overlap oral aripiprazole x3 weeks
Aripiprazole lauroxil (Aristada) Clinical
2D6, 3A4 substrate
LAI dosage form only, dose adjustments for 2D6/3A4 inhibitors and/or 3A4 inducers
Asenapine (Saphris) Dosing
Sublingual tablet